Find a copy online
Find a copy in the library
Finding libraries that hold this item...
Details
Document Type: | Article |
---|---|
All Authors / Contributors: | Javed Ather Siddiqui; Shazia Farheen Qureshi; Muhammed Hamdi; Abdullah Alzahrani |
ISSN: | 2348-9995 |
Language Note: | English |
Unique Identifier: | 8539125170 |
Awards: |
Abstract:
Clozapine is the second-generation antipsychotic which is approved by the US Food and Drug Administration for the treatment of refractory schizophrenia. Clozapine is unfortunately associated with number of adverse effects, one of the chief concerns is agranulocytosis and occasionally leukocytosis, i.e. elevation of white blood cell count. In some cases, the leukocytosis may be persistent. We report the case of a 65-year-old patient diagnosed with schizophrenia, who also fulfilled the criteria of treatment-resistant schizophrenia, treated with clozapine as patient experienced leukocytosis.
Reviews
User-contributed reviews
Add a review and share your thoughts with other readers.
Be the first.
Add a review and share your thoughts with other readers.
Be the first.


Tags
Add tags for "Leukocytosis associated with clozapine in elderly patient".
All user tags (3)
View most popular tags as: tag list
| tag cloud
View most popular tags as:
tag list
| tag cloud
- clozapine (by 1 person)
- leukocytosis (by 1 person)
- refractory schizophrenia (by 1 person)
- 1 items are tagged withclozapine
- 1 items are tagged withleukocytosis
- 1 items are tagged withrefractory schizophrenia
Similar Items
User lists with this item (1)
- MY PUBLICATIONS(23 items)
by JAVEDSIDDIQUI updated 2022-02-16